Revision Hip Arthroplasty

3

Review clinical trials related to Revision Hip Arthroplasty. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Post-Market Clinical Follow-Up (PMCF) Study Evaluating the Safety and Efficacy of Tıpmed™ Revision Hip Prosthesis System

This is a multicenter, prospective, observational, post-market clinical follow-up (PMCF) study designed to evaluate the safety and clinical performance of the Tipmed™ Revision Hip Prosthesis System in adult participants undergoing revision hip arthroplasty. The study aims to gather real-world clinical evidence on the 24-month post-operative safety profile, potential complications, and functional outcomes of the device during routine clinical practice.

Participants needed: 35
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: TIPMED Medical Device Manufacturing Ltd. Co.Updated: Jun 18, 2026Locations: 4
Eligibility criteria

Individuals aged 18 years and older, [+5]

Subjects currently participating in any other interventional clinical trial.

Status: Recruiting

M-Vizion™ Macroscopic Radiographic Study

Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.

Participants needed: 70
Trial details
Age: 21-80Biological sex: AllType: ObservationalSponsor: Medacta USAUpdated: May 8, 2025Locations: 7
Eligibility criteria

Must be able to read, understand, and provide written informed consent on the In... [+5]

Patients with neuromuscular or neurosensory deficiency, which would limit the ab... [+4]

Status: Not yet recruiting

Cementation of Cup and the Risk of Second Revision

Background: The fixation method of the acetabular component during the primary total hip arthroplasty (THA) affects the surgical techniques implemented in the revision surgery and may influence the risk of second revision. Objectives: The objectives of this study are to investigate the risk of second revision of the cup alone or any component after first cup revision following cemented or non-cemented cup in the primary THA. Methods/design: The study is a nationwide register-based cohort study and will follow the reporting of studies Conducted using Observational Routinely collected health Data (RECORD) guidelines. We will compare the risk of undergoing a second revision between cemented and uncemented revised acetabular component by reporting the absolute risk of second revision of 1) the acetabular component and 2) any other component. The cumulative incidence of revision will be estimated using Fine-Gray regression to model the cumulative incidence function, accounting for the competing risk of death. We will apply both a crude and a multivariable adjusted model adjusting for age, sex, Charlson Comorbidity Index (CCI) and the 5-year intervals during which the primary operation was performed.

Participants needed: 60,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Bispebjerg HospitalUpdated: Sep 19, 2024Duration: 15 Years
Eligibility criteria

Primary osteoarthritis as the indication for the primary THA. [+3]

Isolated revision of the femoral component. [+2]